Picture of Zueblin Immobilien Holding AG logo

ZUBN — Zueblin Immobilien Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsAdventurousSmall CapMomentum Trap

Swiss stocks - Factors to watch on Oct 1

ZURICH, Oct 1 (Reuters) - Swiss stocks were expected to open 
lower on Wednesday, mirroring expected falls on other European 
exchanges, as losses on Wall Street and weak macro data weighed 
on sentiment. 
    The Swiss blue-chip SMI  .SSMI  was seen slipping 0.3 
percent at the open to 8,813 points, according to premarket 
indications from bank Julius Baer  JBPRE01 . 
    The following are some of the main factors expected to 
affect Swiss stocks on Wednesday: 
     
    NOVARTIS  NOVN.VX  
    A federal judge said Novartis AG must face a U.S. government 
lawsuit accusing the Swiss drugmaker of paying 
multimillion-dollar kickbacks, including a $9,750 dinner for 
three at a Japanese restaurant, to induce doctors to prescribe 
its drugs. 
    For more, click on:  NOVN.VX  
     
    UBS  UBSN.VX  
    Swiss bank UBS must deposit a 1.1 billion-euro ($1.39 
billion) guarantee on Tuesday to cover potential fines should it 
be found guilty of helping rich French customers avoid tax, a 
source familiar with the court procedure said. 
    For more, click on:  UBSN.VX  
     
    JULIUS BAER  BAER.VX  
    Swiss private bank Julius Baer is cooperating in a French 
investigation into suspected money laundering and tax fraud by a 
former client involved in the European carbon allowances market, 
a spokeswoman said, following French media reports. 
    For more, click on:  BAER.VX  
 
    COMPANY STATEMENTS  CPR-CH  
    * SGS  SGSN.VX  said it had bought Rontgen Technische Dienst 
NV, the non destructive testing activities of Applus+ in 
Belgium, for an undisclosed price. Applus+ RTD Belgium had 
revenues of 6.5 million euros ($8.2 million) in 2013.  SGSN.VX  
    * Novartis  NOVN.VX  will present 15 abstracts from 
its specialty dermatology portfolio at the European Association 
of Dermatology and Venereology (EADV) Congress in Amsterdam on 
8-12 October.  NOVN.VX  
    * Zurich Insurance Group  ZURN.VX  said its Brazilian 
subsidiary had entered into an agreement with Via Varejo for the 
exclusive sale of extended warranty insurance.  ZURN.VX  
    * Danaher Corporation  DHR.N  has published the public 
tender offer for all publicly held shares of Nobel Biocare 
 NOBN.S  with a par value of 0.40 Sfr each.  NOBN.S  
    * Aryzta  ARYN.VX  said it would issue a 145 million Swiss 
franc hybrid instrument with a coupon of 3.5 percent. It said 
proceeds from the issue would be used to refinance existing debt 
and/or for general corporate purposes.  ARYN.VX  
    * Zueblin Immobilien Holding  ZUBN.S  named Iosif Bakaleynik 
as its new chief executive.  ZUBN.S  
    * Partners Group  PGHN.S  has closed a real estate secondary 
program at its hard cap of $1.95 billion.  PGHN.S  
    * Swiss Life  SLHN.VX  has completed its acquisition of 
Corpus Sireo.  SLHN.VX  
    * Sulzer  SUN.S  said it completed the acquisition of Ascom 
B.V. and ProLabNL B.V.  SUN.S  
    * Bellevue Group  BBN.S  said it concluded the acquisition 
of Adamant Biomedical Investments AG from Zuercher 
Kantonalbank ZKB.UL .  BBN.S   
     
    ECONOMY  M-CH  
    * Swiss purchasing managers' index for September due at 0730 
GMT. Analysts in a Reuters poll expect the index to fall to 52.0 
from 52.9 in the previous month.  ECONCH       
 
 
     
    ((Zurich newsroom +41 58 306 7340, fax 41 44 251 0476,  
zurich.newsroom@news.reuters.com))  
 
 
(1 US dollar = 0.7926 euro)

Recent news on Zueblin Immobilien Holding AG

See all news